Laborie Medical Technologies announced today that it completed the acquisition of drug-coated balloon developer Urotronic. The companies struck an agreement last month for Laborie to buy Urotronic for up to $600 million. Urotronic developed the Optilume DCB used in interventional urology procedures. It treats urethral strictures and benign … [Read more...] about Laborie acquires drug-coated balloon maker Urotronic
Catheters
Boston Scientific shares positive drug-coated balloon data
Boston Scientific [WtwhTicker symbol="BSX"](NYSE: BSX)[/WtwhTicker] announced positive data from a trial of its Agent drug-coated balloon (DCB). The Marlborough, Massachusetts-based company presented its results at the Transcatheter Cardiovascular Therapeutics (TCT) meeting. Data demonstrated statistical superiority for Agent compared to … [Read more...] about Boston Scientific shares positive drug-coated balloon data
The biggest cardiovascular stories from TCT 2023
Every year, some of the biggest names in cardiovascular technologies come together in one place for TCT. This year's 35th edition of the Transcatheter Cardiovascular Therapeutics annual scientific symposium was no different in San Francisco. Usual suspects like Medtronic and Abbott had data on display for a range of products, while other big … [Read more...] about The biggest cardiovascular stories from TCT 2023
AVS is developing a new method of intravascular lithotripsy
Amplitude Vascular Systems (AVS) is working on a new way to treat severely calcified arterial disease. The name of the company’s peripheral intravascular lithotripsy (IVL) system is Pulse. The Boston-based startup could start enrolling patients in an investigational device exemption (IDE) study as soon as next year. AVS Chief Operating … [Read more...] about AVS is developing a new method of intravascular lithotripsy
Linear Health Sciences wins expanded indication for Orchid SRV safety release valve
Linear Health Sciences recently announced it received expanded indication from the FDA for its Orchid SRV safety release valve. The expanded indication allows Orchid SRV to be used with all IV access methods. Orchid SRV is a sterile, single-use connector for needle-free access that makes a return to treatment quicker and more simple. It is … [Read more...] about Linear Health Sciences wins expanded indication for Orchid SRV safety release valve
Shockwave Medical launches new coronary IVL catheter following FDA approval
Shockwave Medical announced today that it unveiled a new coronary intravascular lithotripsy (IVL) catheter in the U.S. The planned introduction of the Shockwave C2+ coronary IVL catheter follows the receipt of FDA approval. This catheter offers 50% more pulses per catheter than the Shockwave C2 catheter that the FDA approved in June … [Read more...] about Shockwave Medical launches new coronary IVL catheter following FDA approval
Merit Medical launches expanded Maestro microcatheter line
Merit Medical Systems this week announced the launch of its expanded Maestro microcatheter product line. The Maestro product line features embolotherapy devices, which include Embosphere Microspheres. The new 165 cm Maestro length will be available in 2.1F, 2.4F, 2.8F and 2.9F catheter diameters to support a broad range of embolization … [Read more...] about Merit Medical launches expanded Maestro microcatheter line
B. Braun launches Introcan Safety 2 IV catheter
B. Braun Medical — known for its focus on infusion therapy — has released its Introcan Safety 2 IV catheter, equipped with multi-access blood control. This addition to B. Braun's line of passive needlestick prevention catheters emphasizes minimizing potential risks during the IV process. In addition to automatic needlestick protection, … [Read more...] about B. Braun launches Introcan Safety 2 IV catheter
WhiteSwell fluid removal system produces positive study results
WhiteSwell announced positive initial results from its DELTA-HF trial evaluating its eLym system for excess fluid removal. Galway, Ireland-based WhiteSwell designed eLym to treat acute decompensated heart failure (ADHF). It presented data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 in Cleveland, Ohio. The … [Read more...] about WhiteSwell fluid removal system produces positive study results
Biosense Webster: catheter ablation leads to lower heart failure risk in AFib patients
Johnson & Johnson's Biosense Webster today announced data supporting the use of catheter ablation in AFib patients. The study, funded by the Irvine, California-based company, looked at heart failure incidence risks in AFib patients. It compared the use of catheter ablation versus antiarrhythmic drugs (AAD). Looking at non-specific catheter … [Read more...] about Biosense Webster: catheter ablation leads to lower heart failure risk in AFib patients